Subependymal giant cell astrocytoma diagnostic study of choice

	Subependymal giant cell astrocytoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Subependymal Giant Cell Astrocytoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Subependymal giant cell astrocytoma diagnostic study of choice On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Subependymal giant cell astrocytoma diagnostic study of choice All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Subependymal giant cell astrocytoma diagnostic study of choice
CDC on Subependymal giant cell astrocytoma diagnostic study of choice
Subependymal giant cell astrocytoma diagnostic study of choice in the news
Blogs on Subependymal giant cell astrocytoma diagnostic study of choice
Directions to Hospitals Treating Ependymoma
Risk calculators and risk factors for Subependymal giant cell astrocytoma diagnostic study of choice

Overview

The diagnosis of subependymal giant cell astrocytoma can be made with either an MRI or CT can.

Diagnostic Study of Choice

Study of choice

There is no single diagnostic study of choice for the diagnosis of subependymal giant cell astrocytoma, but subependymal giant cell astrocytoma can be diagnosed based on contrast enhanced MRI and CT scan.^[1]

Diagnostic results

The following finding(s) on performing MRI is(are) confirmatory for subependymal giant cell astrocytoma:^[1]^[2]

T1 isointense and hypointense signal enhancement
T2 isointense and hyperintense signal enhancement
Homogenous postcontrast enhancement

References

↑ ^1.0 ^1.1 Stein JR, Reidman DA (2016). "Imaging Manifestations of a Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis". Case Rep Radiol. 2016: 3750450. doi:10.1155/2016/3750450. PMC 4752974. PMID 26942030.
↑ Beaumont, Thomas L.; Godzik, Jakub; Dahiya, Sonika; Smyth, Matthew D. (2015). "Subependymal giant cell astrocytoma in the absence of tuberous sclerosis complex: case report". Journal of Neurosurgery: Pediatrics. 16 (2): 134–137. doi:10.3171/2015.1.PEDS13146. ISSN 1933-0707.

Template:WikiDoc Sources

[pmid26942030-1] 1.0 ^1.1 Stein JR, Reidman DA (2016). "Imaging Manifestations of a Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis". Case Rep Radiol. 2016: 3750450. doi:10.1155/2016/3750450. PMC 4752974. PMID 26942030.

[BeaumontGodzik2015-2] Beaumont, Thomas L.; Godzik, Jakub; Dahiya, Sonika; Smyth, Matthew D. (2015). "Subependymal giant cell astrocytoma in the absence of tuberous sclerosis complex: case report". Journal of Neurosurgery: Pediatrics. 16 (2): 134–137. doi:10.3171/2015.1.PEDS13146. ISSN 1933-0707.

[1]

[2]